These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24608857)

  • 1. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.
    Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ
    FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.
    Baker JG
    PLoS One; 2010 Nov; 5(11):e15487. PubMed ID: 21152092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Jun; 63(6):1312-21. PubMed ID: 12761341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site of action of beta-ligands at the human beta1-adrenoceptor.
    Baker JG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1163-71. PubMed ID: 15716385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.
    Baker JG; Proudman RG; Tate CG
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    PLoS One; 2013; 8(11):e77582. PubMed ID: 24250787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains.
    Baker JG; Proudman RG; Hill SJ
    Mol Pharmacol; 2015 Jan; 87(1):103-20. PubMed ID: 25324048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptor.
    Baker JG; Proudman RG; Hawley NC; Fischer PM; Hill SJ
    Mol Pharmacol; 2008 Nov; 74(5):1246-60. PubMed ID: 18687809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human
    Lim VJY; Proudman RGW; Monteleone S; Kolb P; Baker JG
    Mol Pharmacol; 2023 Feb; 103(2):89-99. PubMed ID: 36351797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.
    Gherbi K; Briddon SJ; Hill SJ
    Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor.
    Joseph SS; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):223-6. PubMed ID: 15322738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody raised against a thermo-stabilised β
    Soave M; Cseke G; Hutchings CJ; Brown AJH; Woolard J; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():38-54. PubMed ID: 29102678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.
    Joseph SS; Lynham JA; Grace AA; Colledge WH; Kaumann AJ
    Br J Pharmacol; 2004 May; 142(1):51-6. PubMed ID: 15037517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a secondary state of the human beta3-adrenoceptor.
    Baker JG
    Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.
    Kaumann AJ; Engelhardt S; Hein L; Molenaar P; Lohse M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):87-93. PubMed ID: 11191841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
    Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
    Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
    Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.